Production and in situ localization of cutaneous tumour necrosis factor α (TNF-α) and interleukin 6 (IL-6) following skin sensitization

Cytokine

Volumn 10, Issue 3, 1998, Pages 213-219

  Flint, M S ^a   Dearman, R J ^b   Kimber, I ^b   Hotchkiss, S A M ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

Author keywords

Contact sensitization; Epidermal cytokines; IL 6; TNF

Indexed keywords

ALLERGEN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; OXAZOLONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTACT SENSITIZATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPIDERMIS; FEMALE; GENE EXPRESSION; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SKIN; SKIN SENSITIZATION;

ANIMALIA;

EID: 0032030958     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1997.0278     Document Type: Article

References (32)

1. 1. Kimber I, Dearman RJ (1996) Contact hypersensitivity: immunological mechanisms. In Kimber I, Maurer T (eds) Toxicology of Contact Hypersensitivity, Taylor and Francis, London, pp. 4-25.
2. 2. Enk AH, Katz SI (1992) Early molecular events in the induction phase of contact sensitivity. Proc Natl Acad Sci USA 89:1398-1402.
3. 3. Enk AH, Katz SI (1992) Identification and induction of keratinocyte-derived IL-10. J Immunol 149:92-95.
4. 4. Matsue H, Cruz PD Jr, Bergstresser PR, Takashima A (1992) Langerhans cells are the major source of mRNA for IL-1β and MIP-1α among unstimulated mouse epidermal cells. J Invest Dermatol 99:537-541.
5. 5. Heufler C, Topar G, Koch F, Trockenbacher B, Kampgen E, Romani N, Schuler G (1992) Cytokine gene expression in murine epidermal cell suspensions: interleukin 1β and macrophage inflammatory protein 1α are selectively expressed in Langerhans cells but are differentially regulated in culture. J Exp Med 176:1221-1226.
6. 6. Schreiber S, Kilgus O, Payer E, Kutil R, Elbe A, Mueller C, Stingl G (1992) Cytokine pattern of Langerhans cells isolated from murine epidermal cell cultures. J Immunol 140:3525-3534.
7. 7. Kimber I, Cumberbatch M (1992) Dendritic cells and cutaneous immune responses to chemical allergens. Toxicol Appl Pharmacol 117:137-146.
8. 8. Witmer-Pack MD, Olivier W, Valinsky J, Schuler G, Steinman RM (1987) Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells. J Exp Med 166:1484-1498.
9. 9. Heufler C, Koch F, Schuler G (1988) Granulocyte/ macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. J Exp Med 167:700-705.
10. 10. Ozawa H, Nakagawa S, Tagami H, Aiba S (1996) Interleukin-1β and granulocyte-macrophage colony-stimulating factor mediate Langerhans cell maturation differently. J Invest Dermatol 106:441-445.
11. 11. Furue M, Chang C, Tamaki K (1996) Interleukin-1 but not tumour necrosis factor a synergistically upregulates the granulocyte-macrophage colony-stimulating factor-induced B7-1 expression of murine Langerhans cells. Br J Dermatol 135:194-198.
12. 12. Kimber I, Cumberbatch M (1995) Langerhans cell migration: initiation and regulation. In Moll H (ed.) The Immune Functions of Epidermal Langerhans cells, R G Landes Co, Austin, pp. 103-117.
13. 13. Cumberbatch M, Kimber I (1992) Dermal tumour necrosis factor-α induces dendritic cell migration to draining lymph nodes and possibly provides one stimulus for Langerhans cell migration. Immunology 75:257-263.
14. 14. Cumberbatch M, Fielding I, Kimber I (1994) Modulation of epidermal Langerhans cell frequency by tumour necrosis factor-α. Immunology 81:395-401.
15. 15. Cumberbatch M, Kimber I (1995) Tumour necrosis factor-α is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization. Immunology 84:31-35.
16. 16. Cumberbatch M, Dearman RJ, Kimber I (1996) Constitutive and inducible expression of interleukin-6 by Langerhans cells and lymph node dendritic cells. Immunology 87:513-518.
17. 17. Holliday MR, Dearman RJ, Corsini E, Basketter DA, Kimber I (1996) Selective stimulation of cutaneous interleukin 6 expression by skin allergens. J Appl Toxicol 16:65-70.
18. 18. Holliday MR, Dearman RJ, Basketter DA, Kimber I (1996) Stimulation by oxazolone of increased IL-6, but not IL-10, in the skin of mice. Toxicology 106:237-242.
19. 19. Howie SEM, Aldridge RD, McVittie E, Thornton E, Ramage E, Hunter JAA (1992) A non-radiolabelled in situ hybridization method for the detection of epidermal cytokine mRNA. J Exp Dermatol 1:230-235.
20. 20. Dearman RJ, Hope JC, Hopkins SJ, Debicki RJ, Kimber I (1993) Interleukin 6 (IL-6) production by lymph node cells: an alternative end point for the murine local lymph node assay. Toxicol Methods 3:268-278.
21. 21. Enk AH, Angeloni VL, Udey MC, Katz SI (1993) An essential role for Langerhans cell-derived IL-1β in the initiation of primary immune responses in skin. J Immunol 150:3698-3704.
22. 22. de Kossodo S, Grau GE, Daneva T, Pointaire P, Fossati L, Ody C, Zapf J, Piguet P-F, Gaillard RC, Vassalli P (1992) Tumor necrosis factor α is involved in mouse growth and lymphoid tissue development. J Exp Med 176:1259-1264.
23. 23. Santiago-Schwarz F, Divans N, Kay C, Carsons SE (1993) Mechanisms of tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-induced dendritic cell development. Blood 82:3019-3028.
24. 24. Piguet PF, Grau GE, Hauser C, Vassalli P (1991) Tumor necrosis factor is a critical mediator in hapten-induced irritant and contact hypersensitivity reactions. J Exp Med 173:673-679.
25. 25. Ryffel B, Brockhaus M, Greiner B, Mihatsch MJ, Gudat F (1991) Tumor necrosis factor receptor distribution in human lymphoid tissue. Immunology 74:446-452.
26. 26. Larregina A, Morelli A, Kolkowski E, Fainboim L (1996) Flow cytometric analysis of cytokine receptors on human Langerhans cells. Changes observed after short-term culture. Immunology 87:317-325.
27. 27. Wang B, Kondo S, Shivji GM, Fujisawa H, Mak TW, Sauder DN (1996) Tumour necrosis factor receptor II (p75) signalling is required for the migration of Langerhans cells. Immunology 88:284-288.
28. 28. Berg DJ, Leach MW, Kuhn R, Rajewsky K, Muller W, Davidson NJ, Rennick D (1995) Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses. J Exp Med 182:99-108.
29. 29. Nicod LP, El Habre F, Dayer J-M, Boehringer N (1995) Interleukin-10 decreases tumor necrosis factor α and β in allo-reactions induced by human lung dendritic cells and macrophages. Am J Respir Cell Mol Biol 13:83-90.
30. 30. Gerard C, Bruyns C, Marchant A, Abramowicz D, Vandenbeele P, Delvaux A, Fiers W, Goldman M, Velu T (1993) Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 177:547-550.
31. 31. van Overveld FJ, Jorens Ph G, Rampart M, De Backer W, Vermeire PA (1991) Tumour necrosis factor stimulates human skin mast cells to release histamine and tryptase. Clin Exp Allergy 21:711-714.
32. 2 receptors. J Exp Med 174:281-284.